Financial Statements and Related Announcement::Half Yearly Results

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
Financial Statements and Related Announcement
Date &Time of Broadcast
13-Nov-2021 01:00:19
Status
New
Announcement Sub Title
Half Yearly Results
Announcement Reference
SG211113OTHRVDUV
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
12/11/2021 00:00:00
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format)
Unaudited Financial Results (Standalone and Consolidated) for the Second Quarter and Half Year ended September 30, 2021

Additional Details

For Financial Period Ended
30/09/2021

Attachments

SGX_RESULT_12112021.pdf
Total size =15460K